HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $86,251 | -21.9% | 963 | -25.8% | 0.00% | – |
| Q2 2023 | $110,460 | +6.9% | 1,297 | +4.2% | 0.00% | – |
| Q1 2023 | $103,309 | +11.1% | 1,245 | +5.7% | 0.00% | – |
| Q4 2022 | $93,000 | +12.0% | 1,178 | +4.2% | 0.00% | – |
| Q3 2022 | $83,000 | +6.4% | 1,130 | -5.8% | 0.00% | – |
| Q2 2022 | $78,000 | +34.5% | 1,199 | +12.1% | 0.00% | – |
| Q1 2022 | $58,000 | +18.4% | 1,070 | +14.8% | 0.00% | – |
| Q4 2021 | $49,000 | -54.2% | 932 | -38.2% | 0.00% | – |
| Q3 2021 | $107,000 | +13.8% | 1,508 | +7.0% | 0.00% | – |
| Q2 2021 | $94,000 | -40.5% | 1,410 | -0.6% | 0.00% | – |
| Q1 2021 | $158,000 | -29.8% | 1,418 | -24.7% | 0.00% | -100.0% |
| Q4 2020 | $225,000 | +25.0% | 1,883 | -6.2% | 0.00% | 0.0% |
| Q3 2020 | $180,000 | +1.1% | 2,007 | +1.8% | 0.00% | 0.0% |
| Q2 2020 | $178,000 | -3.8% | 1,972 | +7.7% | 0.00% | 0.0% |
| Q1 2020 | $185,000 | – | 1,831 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |